news
Revolutionary biomass-based plastic used for blister packaging
Astellas' use of biomass-based plastics represents the world's first use of biomass plastic for drug blister packaging.
List view / Grid view
irritable bowel syndrome (IBS)
news
LBPs may offer hope to IBS patients in the near future, says report
Live biotherapeutic products (LBPs) are expected to help patients with IBS who currently have no US- or EMA-approved treatments.
news
Deception is not necessary for the placebo effect, finds new study
The study found that patients with irritable bowel syndrome taking open-label placebo reported similar improvements to those taking double-blind placebo.
news
Vitamin D supplements could ease painful IBS symptoms
Researchers find that vitamin D supplements could help to ease painful Irritable Bowel Syndrome symptoms...
news
RedHill Biopharma enrols last patient in Phase II irritable bowel syndrome trial
26 April 2017 | By Niamh Marriott, Junior Editor
RedHill Biopharma has enrolled the last patient in the Phase II study with Bekinda for the treatment of diarrhoea-predominant irritable bowel syndrome...
news
First patients dosed in Bekinda IBS-D trial
22 June 2016 | By Victoria White, Digital Content Producer
The first patients have been dosed in a Phase II clinical study with RedHill Biopharma’s Bekinda 12 mg for diarrhoea-predominant irritable bowel syndrome...
